These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26398824)

  • 41. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
    Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
    Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
    Chen S; Wang H; Ng WL; Curran WJ; Wang Y
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1524-9. PubMed ID: 22014955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
    Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
    J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of imbalance between the master regulators TTF1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer.
    Vescio M; Bulloni M; Pelosi G; Pattini L
    Sci Rep; 2024 Jan; 14(1):2467. PubMed ID: 38291083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolomics a novel biomarker in lung cancer.
    Stinkens K; Vanhove K; Thomeer M
    J Thorac Oncol; 2015 Jun; 10(6):e46. PubMed ID: 26001150
    [No Abstract]   [Full Text] [Related]  

  • 48. Verifying the role of surgical pathologists in the precision medicine of lung cancer.
    Cagle PT; Olsen RJ
    Arch Pathol Lab Med; 2013 Sep; 137(9):1176-8. PubMed ID: 23276149
    [No Abstract]   [Full Text] [Related]  

  • 49. [TTF1 and p40 co-expression in the same tumor cells in a non-small cell lung carcinoma: a clinicopathological analysis of three cases].
    Guo XM; Xu HM; Chen XY
    Zhonghua Bing Li Xue Za Zhi; 2023 Jan; 52(1):52-54. PubMed ID: 36617908
    [No Abstract]   [Full Text] [Related]  

  • 50. [Research progress of biomarkers in early stage lung cancer].
    Ouyang Yuqing YQ; Ni Lianfang LF; Liu Xinmin XM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):979-981. PubMed ID: 30522198
    [No Abstract]   [Full Text] [Related]  

  • 51. The rapidly evolving landscape of biomarker testing in non-small cell lung cancer.
    VanderLaan PA; Rangachari D; Costa DB
    Cancer Cytopathol; 2021 Mar; 129(3):179-181. PubMed ID: 32757369
    [No Abstract]   [Full Text] [Related]  

  • 52. The significance of p40 expression in sclerosing hemangioma of lung.
    Wu J; Zhang C; Qiao H
    Sci Rep; 2014 Aug; 4():6102. PubMed ID: 25130377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alveolar Pneumocytes Entrapping Pathologists.
    Rossi G; Pereira-Santos P; Cavazza A
    Am J Clin Pathol; 2015 Jul; 144(1):174-5. PubMed ID: 26071477
    [No Abstract]   [Full Text] [Related]  

  • 54. [Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and p40 in the same tumor cells: report of a case].
    Chen B; Cheng N
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):558-560. PubMed ID: 35673733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ASO Author Reflections: Key Components of the Hedgehog Signaling Pathway as Prognostic Biomarkers in Non-small Cell Lung Cancer.
    Herreros-Pomares A; Jantus-Lewintre E
    Ann Surg Oncol; 2023 Feb; 30(2):1236-1237. PubMed ID: 36125572
    [No Abstract]   [Full Text] [Related]  

  • 56. Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma.
    Del Sordo R; Giansanti M; Bellezza G; Sidoni A
    Hum Pathol; 2012 Jul; 43(7):1153-4; author reply 1154. PubMed ID: 22703591
    [No Abstract]   [Full Text] [Related]  

  • 57. Invited commentary.
    D'Amico TA
    Ann Thorac Surg; 2011 Sep; 92(3):1050. PubMed ID: 21871298
    [No Abstract]   [Full Text] [Related]  

  • 58. Microenvironment: HSF1, the troublemaker next door.
    Villanueva MT
    Nat Rev Cancer; 2014 Sep; 14(9):579. PubMed ID: 25118604
    [No Abstract]   [Full Text] [Related]  

  • 59. Regarding the manuscript of Huang et al. published in Acta Histochemica (doi:10.1016/j.acthis.2010.06.003).
    Tang BL; Lim YS
    Acta Histochem; 2011 Oct; 113(6):677-8; author reply 675-6. PubMed ID: 20926121
    [No Abstract]   [Full Text] [Related]  

  • 60. The Isoform Matters in NUT Carcinoma: A Diagnostic Pitfall of p40 Immunohistochemistry.
    Matsuda K; Kashima J; Yatabe Y
    J Thorac Oncol; 2020 Oct; 15(10):e176-e178. PubMed ID: 32981612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.